30 Participants Needed

Online Intervention for HIV/AIDS

(ORCHID-Miami Trial)

Recruiting at 1 trial location
LM
LD
WB
Overseen ByWilmar B Mondestin, MSPS
Age: 18+
Sex: Female
Trial Phase: Academic
Sponsor: University of Miami
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your healthcare provider.

What data supports the effectiveness of the treatment ORCHID for HIV/AIDS?

Research shows that online self-management programs can improve quality of life and coping skills for people with HIV, as seen in the Positive Outlook Study, which helped participants manage emotional distress and social relationships. Additionally, technology-based interventions have been shown to enhance medication adherence and resilience, suggesting that online treatments like ORCHID could be beneficial.12345

Is the online intervention for HIV/AIDS, known as ORCHID, safe for humans?

The research articles provided do not contain specific safety data for the online intervention ORCHID or its other names. They focus on coping strategies and interventions for managing HIV treatment side effects, but do not address the safety of the ORCHID intervention itself.678910

What makes the ORCHID treatment unique for HIV/AIDS?

The ORCHID treatment is unique because it is an online intervention designed to enhance resilience and coping skills for people living with HIV/AIDS, focusing on psychological and social support rather than just medication. This approach is novel as it leverages internet delivery to provide accessible support, which can be particularly beneficial in resource-limited settings.23111213

What is the purpose of this trial?

The purpose of this research is to test ORCHID (Optimizing Resilience \& Coping with HIV through Internet Delivery), a skills-building intervention that improves mental health status for persons with HIV, who are at-risk for falling out of care.

Research Team

LM

Lunthita M Duthely, Ed.D.

Principal Investigator

University of Miami

Eligibility Criteria

The ORCHID trial is for adult women with HIV who are treated at the University of Miami Women's HIV Service. They must have had HPV or related health issues in the past year and may struggle with substance use or mental health conditions like depression, anxiety, or PTSD. Participants should not be cognitively impaired, imprisoned, under 18, unable to read/write English at a basic level, or have severe psychiatric disorders.

Inclusion Criteria

I am a cisgender woman with HIV receiving care at the University of Miami.
I have had cervical or anal issues, HPV, or mental health/drug use problems in the last year.

Exclusion Criteria

Not able to read/write English at the 6th grade level
Cognitively impaired adults (as documented in medical records)
Prisoners
See 1 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive the ORCHID online intervention to improve mental health status for up to 6 months

6 months
8 online sessions

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • ORCHID
Trial Overview ORCHID is an online program designed to help improve mental well-being in women living with HIV. It focuses on building skills to cope better and stay engaged in their healthcare. The study will evaluate how effective this intervention is for those who might be at risk of dropping out of care due to various challenges.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: ORCHID GroupExperimental Treatment1 Intervention
Participants in the ORCHID group will receive an online intervention that improves depressive symptoms and positive affect (emotions) for clinic-based persons living with HIV, for up to 6 months.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Miami

Lead Sponsor

Trials
976
Recruited
423,000+

Northwestern University

Collaborator

Trials
1,674
Recruited
989,000+

Findings from Research

The Positive Outlook Program, a 7-week online self-management program for HIV-positive gay men, significantly improved health-related quality of life and self-efficacy in managing psychosocial issues, as shown by positive outcomes in various subscales measured at baseline, post-intervention, and 12 weeks later.
Participants in the intervention group reported notable improvements in areas such as body change, social relationships, emotional distress, and health-directed activities, indicating that online self-management programs can effectively enhance well-being and coping skills for this population.
The Positive Outlook Study: A Randomised Controlled Trial Evaluating Online Self-Management for HIV Positive Gay Men.Millard, T., Agius, PA., McDonald, K., et al.[2019]
A longitudinal study of 61 HIV-positive individuals showed that overall distress decreased significantly over 1.5 years, indicating that many people adapt well to living with HIV and maintain a good quality of life.
However, those with high distress levels, particularly drug users, often used ineffective coping strategies and reported a low quality of life, highlighting the need for professional support like psychotherapy for this vulnerable group.
Longitudinal development of distress, coping and quality of life in HIV-positive persons.Leiberich, P., Engeter, M., Olbrich, E., et al.[2019]
A qualitative study involving 28 participants from a pilot trial in rural Uganda found that many individuals living with HIV demonstrated resilience in adhering to antiretroviral therapy (ART) after the withdrawal of a technology-based adherence support intervention, indicating that they internalized the habit of medication adherence.
While most participants developed effective coping strategies and maintained adherence, a minority struggled without the intervention, highlighting the importance of ongoing support and the variability in individual resilience and social support systems.
Resilience after withdrawing a technology-based medication adherence support intervention from people living with HIV in rural Uganda.Musiimenta, A., Atukunda, EC., Tumuhimbise, W., et al.[2023]

References

The Positive Outlook Study: A Randomised Controlled Trial Evaluating Online Self-Management for HIV Positive Gay Men. [2019]
Longitudinal development of distress, coping and quality of life in HIV-positive persons. [2019]
Resilience after withdrawing a technology-based medication adherence support intervention from people living with HIV in rural Uganda. [2023]
Religious coping and physiological, psychological, social, and spiritual outcomes in patients with HIV/AIDS: cross-sectional and longitudinal findings. [2022]
Coping in cyberspace: the impact of Internet use on the ability of HIV-positive individuals to deal with their illness. [2018]
Personal coping strategies for managing the side effects of antiretroviral therapy among patients at an HIV/AIDS clinic in Uganda. [2022]
Overcoming Barriers to HIV Treatment Adherence: A Brief Cognitive Behavioral Intervention for HIV-Positive Adults on Antiretroviral Treatment. [2022]
E-VOLUTION: A Text Messaging-Powered Intervention-Connection, Support, and HIV Eradication. [2021]
Coping with HIV treatment side effects: conceptualization, measurement, and linkages. [2022]
10.United Statespubmed.ncbi.nlm.nih.gov
Enhancing Lay Counselor Capacity to Improve Patient Outcomes with Multimedia Technology. [2022]
Patterns of coping among persons with HIV infection: configurations, correlates, and change. [2021]
From surviving to thriving: the role of resilience in meeting global HIV goals. [2023]
Living with HIV: coping strategies of seropositive older adults. [2021]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security